TBPH - Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01 revenue of $14.51M beats by $0.56M
2024-05-13 16:19:09 ET
More on Theravance Biopharma
- Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript
- Theravance Biopharma, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Theravance Biopharma Q1 2024 Earnings Preview
- Theravance Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $17.6M beats by $0.03M
- Seeking Alpha’s Quant Rating on Theravance Biopharma